NeuroSense Therapeutics (NRSN) Cash & Equivalents (2020 - 2025)
NeuroSense Therapeutics' (NRSN) quarterly Cash & Equivalents came in at $166000.0 in Q4 2025, down 95.09% year-over-year from $3.4 million in Q4 2024, and down 75.08% quarter-over-quarter from $666000.0 in Q2 2025.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Cash & Equivalents (2020 - 2025) Analysis & Trends
NeuroSense Therapeutics has disclosed Cash & Equivalents across 6 years of filings, most recently posting $166000.0 for Q4 2025.
- In Q4 2025, Cash & Equivalents fell 95.09% year-over-year to $166000.0; the TTM figure through Dec 2025 stood at $166000.0 (down 95.09% YoY), while the FY2025 annual figure was $166000.0, down 95.09% from the prior year.
- Cash & Equivalents came in at $166000.0 for Q4 2025 at NeuroSense Therapeutics, down from $666000.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $8.7 million in Q1 2022 to a low of $166000.0 in Q4 2025.
- Average Cash & Equivalents over 5 years is $3.0 million, with a median of $3.4 million recorded in 2024.
- Year-over-year, Cash & Equivalents soared 406.87% in 2022 and tumbled 95.09% in 2025.
- Over 5 years, Cash & Equivalents stood at $699000.0 in 2021, then soared by 406.87% to $3.5 million in 2022, then changed by 0.0% to $3.5 million in 2023, then dropped by 4.66% to $3.4 million in 2024, then plunged by 95.09% to $166000.0 in 2025.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $166000.0 in Q4 2025, $666000.0 in Q2 2025, and $3.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 208.48 Bn | 194.49 Bn | 7.24 Bn | 13.99 Bn |
| 2 | Gilead Sciences | 186.29 Bn | 183.02 Bn | 6.22 Bn | 3.18 Bn |
| 3 | Vertex Pharmaceuticals | 128.79 Bn | 120.93 Bn | 2.84 Bn | 6.14 Bn |
| 4 | Regeneron Pharmaceuticals | 80.66 Bn | 72.67 Bn | 3.93 Bn | 2.46 Bn |
| 5 | Moderna | 61.46 Bn | 56.32 Bn | 52.00 Mn | 1.72 Bn |
| 6 | Argenx Se | 61.28 Bn | 56.10 Bn | 1.37 Bn | 3.58 Bn |
| 7 | Alnylam Pharmaceuticals | 32.04 Bn | 28.73 Bn | 992.69 Mn | 1.71 Bn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | 1.29 Bn |
| 9 | Roivant Sciences | 28.74 Bn | 29.43 Bn | 1.16 Mn | 1.25 Bn |
| 10 | NeuroSense Therapeutics | 8.09 Mn | 7.88 Mn | - | 166,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 166,000.00 |
| Jun 30, 2025 | 666,000.00 |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | 344,000.00 |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 3.54 Mn |
| Sep 30, 2023 | 4.76 Mn |
| Jun 30, 2023 | 7.09 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 3.54 Mn |
| Sep 30, 2022 | 4.41 Mn |
| Jun 30, 2022 | 4.35 Mn |
| Mar 31, 2022 | 8.74 Mn |
| Dec 31, 2021 | 699,000.00 |
| Dec 31, 2020 | 699,000.00 |
API Access
NeuroSense Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();